Skip to main content

Mesoblast Ltd

MESO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001345099

No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.

Other share classesMEOBF

Q1 2024 vs. Q4 2023

How the institutions holding Mesoblast Ltd changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of MESO: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3126−5
SharesConverted for a 1-for-2 split724.9K1.08M+359.5K (+49.6%)
Value$1.59M$5.48M+$3.89M (+243.7%)

New holders (9)

Institutions that held Mesoblast Ltd at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to MESO in Q1 2024
InstitutionSharesValue% of portfolio
VGI Partners Ltd117,243$587.4K0.06%
Prosperity Wealth Management, Inc.77,350$387.5K0.18%
Chase Investment Counsel Corp59,600$298.0K0.11%
HRT Financial LP57,815$289.0K0.00%
Fi3 FINANCIAL ADVISORS, LLC20,200$151.5K0.07%
Tobias Financial Advisors, Inc.10,000$50.1K0.01%
Tower Research Capital LLC (TRC)3,410$17.1K0.00%
Comerica Bank993$4.97K0.00%
Cutler Group LP500$2.00K0.00%

Sold out (14)

Institutions that held Mesoblast Ltd at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of MESO in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Lattice Capital Management, LLC30,100$33.1K
Rathbone Brothers plc24,435$26.9K
FNY Investment Advisers, LLC20,000$22.0K
Diligent Investors, LLC11,000$12.1K
XTX Topco Ltd10,847$11.9K
Jane Street Group, LLC10,008$11.0K
Aries Wealth Management10,000$11.0K
Blue Zone Wealth Advisors, LLC10,000$11.0K
Citadel Advisors LLC5,337$5.87K
Qube Research & Technologies Ltd4,183$4.60K
UBS Group AG1,700$1.87K
Ronald Blue Trust, Inc.1,163$1.00K
Arlington Trust Co LLC172$189
Royal Bank of Canada192$0